All members have the option of attending our various HTC-centric events which include:
Date: Tuesday, June 25, 2024
Time: 1:00pm – 2:00pm ET
Title: Wilate Prophylaxis in VWD – Results from the WIL-31 Study
Objectives:
1) Understand the bleeding symptoms experienced by folks with von Willebrand disease
2) Understand the benefits of wilate prophylaxis in von Willebrand disease across different ages and types
3) Understand the lack of von Willebrand factor and FVIII accumulation during wilate prophylaxis
Speaker:
Claudio Sandoval
Senior Director of Scientific & Medical Affairs at Octapharma
Claudio Sandoval is the Senior Director of Scientific & Medical Affairs at Octapharma. Before his current role he was a pediatric hematologist-oncologist for 30 years caring for children with bleeding disorders, cancer, sickle cell disease, and other maladies. Claudio graduated from New York Medical College and trained at Schneider Children’s Hospital in New Hyde Park, NY and St. Jude Children’s Research Hospital in Memphis, TN.
